Financial Architects, Inc - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 16 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Financial Architects, Inc ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$0–10.0%0.00%–
Q2 2018$0–10.0%0.00%–
Q1 2018$0–10.0%0.00%–
Q4 2017$0–10.0%0.00%–
Q3 2017$0–10.0%0.00%–
Q2 2017$0–10.0%0.00%–
Q1 2017$0–10.0%0.00%–
Q4 2016$0–1–0.00%–
 Download
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q2 2017
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 86,530$22,0000.00%
Virtu Financial LLC 124,195$32,0000.00%
BARCLAYS PLC 50$00.00%
VANGUARD GROUP INC 285,154$74,0000.00%
UBS Group AG 32,270$8,0000.00%
Tradewinds Capital Management, LLC 200$00.00%
Rehmann Capital Advisory Group 69$18,0000.00%
IFP Advisors, Inc 95$00.00%
Jacobi Capital Management LLC 125$00.00%
WELLS FARGO & COMPANY/MN 250$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders